Search by Drug Name or NDC

    NDC 50268-0440-15 Irbesartan 75 mg/1 Details

    Irbesartan 75 mg/1

    Irbesartan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is IRBESARTAN.

    Product Information

    NDC 50268-0440
    Product ID 50268-440_026bef1a-3fd5-426b-e063-6294a90abe96
    Associated GPIs 36150030000310
    GCN Sequence Number 034470
    GCN Sequence Number Description irbesartan TABLET 75 MG ORAL
    HIC3 A4F
    HIC3 Description ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST
    GCN 04752
    HICL Sequence Number 015576
    HICL Sequence Number Description IRBESARTAN
    Brand/Generic Generic
    Proprietary Name Irbesartan
    Proprietary Name Suffix n/a
    Non-Proprietary Name Irbesartan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 75
    Active Ingredient Units mg/1
    Substance Name IRBESARTAN
    Labeler Name AvPAK
    Pharmaceutical Class Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202910
    Listing Certified Through 2024-12-31

    Package

    NDC 50268-0440-15 (50268044015)

    NDC Package Code 50268-440-15
    Billing NDC 50268044015
    Package 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-440-15) / 1 TABLET in 1 BLISTER PACK (50268-440-11)
    Marketing Start Date 2023-08-08
    NDC Exclude Flag N
    Pricing Information N/A